Globus Medical Q2 EPS $0.63 Beats $0.59 Estimate, Sales $291.62M Beat $279.72M Estimate
Portfolio Pulse from Benzinga Newsdesk
Globus Medical (NYSE:GMED) reported Q2 earnings of $0.63 per share, beating the analyst consensus estimate of $0.59 by 6.78%. This is a 12.5% increase from the same period last year. The company also reported quarterly sales of $291.62 million, beating the analyst consensus estimate of $279.72 million by 4.25%, a 10.61% increase from the same period last year.
August 04, 2023 | 2:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Globus Medical's Q2 earnings and sales exceeded analyst estimates, indicating a strong financial performance.
Globus Medical's Q2 earnings and sales beat analyst estimates, which is a positive signal for the company's financial performance. This could lead to increased investor confidence and potentially a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100